agilon health, inc. (AGL)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 1,394,982 | 1,532,782 | 1,450,932 | 1,482,758 |
| Expenses | - | 1,482,060 | 1,505,950 | 1,450,583 |
| General and administrative | 56,281 | 65,956 | 63,123 | 69,612 |
| Depreciation and amortization | 7,319 | 6,876 | 6,218 | 5,907 |
| Expenses-Other Operating | 2,164 | - | - | - |
| Expenses-Medical Services | 1,445,245 | - | - | - |
| Total expenses | 1,511,009 | 1,554,892 | 1,584,440 | 1,526,102 |
| Income (loss) from operations | -116,027 | -22,110 | -133,508 | -43,344 |
| Other income (expense), net | 7,879 | 9,261 | 16,061 | 4,841 |
| Interest expense | 1,572 | 1,515 | 1,622 | 1,697 |
| Income (loss) from equity method investments | 5,412 | 12,672 | 2,047 | 9,955 |
| Income (loss) before income taxes | -104,308 | -1,692 | -117,022 | -30,245 |
| Income tax benefit (expense) | 62 | 196 | -590 | 417 |
| Income (loss) from continuing operations | -104,370 | -1,888 | -116,432 | -30,662 |
| Income (loss) before gain (loss) on sales | - | - | -1,183 | - |
| Adjustments on sale of assets, net | - | 14,000 | - | - |
| Total discontinued operations | - | 14,000 | -1,183 | - |
| Net income (loss) | -104,370 | 12,112 | -117,615 | -30,662 |
| Noncontrolling interests share in (earnings) loss | - | - | - | 20 |
| Net income (loss) attributable to common shares | -104,370 | 12,112 | -117,615 | -30,682 |
| Weighted average shares outstanding basic (in shares) | 413,836,000 | 412,936,000 | 411,591,000 | 411,271,000 |
| Weighted average shares outstanding diluted (in shares) | 413,836,000 | 412,936,000 | 411,591,000 | 411,271,000 |